Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

Systematic evidence mapping for updating health reference values: A case example using acrolein - Poster

On this page:

  • Overview
Transparent, methodologically rigorous, and rapid approaches are needed for updating human health assessments. Evidence mapping is a potentially helpful type of systematic review analysis, especially when combined with machine-learning software advances. In a case study with acrolein, we evaluated the applicability of evidence mapping to determine whether new evidence may result in a change to an existing health reference value using the 2008 California EPA assessment as the reference point. In addition, the evidence map identified studies that might not be suitable for reference value derivation but could be important to consider for hazard characterization or to identify emerging areas that should be explored in future research. Over 13,000 studies were identified, and 40 studies considered relevant after full-text review. Most of these studies were short-term exposure animal studies and not considered suitable for deriving a chronic reference value. The epidemiology studies identified had limitations in exposure assessment or ability to use the exposure metric to derive an inhalation value. After considering the relevant studies identified from the evidence map, the 2008 subchronic rat study used by the California EPA for their reference value derivation appear to still be the most appropriate study for chronic reference value derivation for acrolein. Additionally, we identified new advances in dosimetric modeling for gases, including new evidence pertinent to acrolein, which could be considered for updating existing acrolein toxicity values. Further details from this analysis will be presented. In conclusion, evidence mapping appears to be a useful tool for human health risk assessment.

Impact/Purpose

This poster will be presented at the 50th Environmental Mutagenesis and Genomics Society Annual Meeting on September 19-23, 2019.

Citation

Keshava, C., J. Davis, J. Stanek, Kristina Chialton, A. Galizia, Nagalakshmi Keshava, J. Gift, Suryanarayana Vulimiri, G. Woodall, C. Gigot, A. Greenhalgh, B. Schultz, S. Volkoff, K. Camargo, AND A. Persad. Systematic evidence mapping for updating health reference values: A case example using acrolein - Poster. EMGS, Washington, District Of Columbia, September 19 - 23, 2019.
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on June 17, 2021
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.